INmune Bio (INMB) Earnings Date & Reports

INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

INMB is expected to report earnings to fall 6.25% to -18 cents per share on August 05

Q2'26

Est.

$-0.19

Q1'26

Beat

by $0.07

Q4'25

Beat

by $0.05

Q3'25

Beat

by $0.09

Q2'25

Missed

by $0.65

The last earnings report on May 07 showed earnings per share of -20 cents, beating the estimate of -27 cents. With 263.52K shares outstanding, the current market capitalization sits at 38.02M.

View a ticker or compare two or three

Compare

INMB

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for INMB